PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
03-Oct-2022 Kuros Biosciences Appoints Chris Fair as Chief Operating Officer Kuros Biosciences AG
03-Oct-2022 Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate Relief Therapeutics Holding SA
03-Oct-2022 Future Markets Research Releases Commentary on NurExone Biologic Inc, An Emerging Leader in The Exosomal Treatment of Spinal Cord Injury Businesswire
02-Oct-2022 New Data Reveal Molecular Drivers of Thyroid Eye Disease (TED) May Remain Activated In Patients with Low Clinical Activity Score (CAS) Businesswire
02-Oct-2022 Pentoxyverine Market Key Players, End User Demand And Analysis Growth Trends By 2030 We Market Research
02-Oct-2022 Bio Farma secures multi-year Purchase Contract from UNICEF for its novel Oral Polio Vaccine type 2 (nOPV2) PT Bio Farma (Persero) / BUMN
01-Oct-2022 Rare Disease PTEN Hamartoma Tumour Syndrome (PHTS) Granted International Classification of Diseases (ICD) Code Businesswire
30-Sep-2022 ABIVAX ANNOUNCES THE RELEASE OF ITS 2022 HALF-YEAR FINANCIAL REPORT ABIVAX
30-Sep-2022 Energy crisis forcing companies to take extensive cost-cutting action, research finds Ayming
30-Sep-2022 Kingston University PhD student wins national Vitae Three Minute Thesis competition for research that could help address global organ donor shortage Kingston University
30-Sep-2022 Biognosys Expands Its Global Presence with a US Office in Biopharma Hub Cambridge, Massachusetts Biognosys
30-Sep-2022 Kinarus Therapeutics Announces Discontinuation of the Phase 2 KINETIC Study of KIN001 in Hospitalized COVID-19 Patients Following a Prespecified Interim Analysis of Efficacy and Safety Kinarus Therapeutics
30-Sep-2022 Biolog-id completed phase one of deploying its value-chain optimization solution in a multi-state integrated delivery network in the southeast USA Biolog-id
30-Sep-2022 Cosmetic Implants Market Size to Reach US$ 17.9 Billion by 2022-2032) CAGR of 5.8% | FMI Research MARKITWIRED
30-Sep-2022 ProBioGen Celebrates "A New Dawn in Biotechnology" B3C newswire
30-Sep-2022 Non-Vascular Stents Market worth US$ 1.9 billion by 2032 & CAGR of 4.5% | FMI MARKITWIRED
30-Sep-2022 Pharmiweb.Jobs Welcomes William Parker Group William Parker Group
30-Sep-2022 Motion Stimulation Therapy Market Size Worth US$ 1.8 Million | Exclusive Report by FMI MARKITWIRED
30-Sep-2022 Bone Cement Delivery Systems Market– Global Industry Analysis and Deeper Insights | FMI MARKITWIRED
30-Sep-2022 Therapeutic Apheresis Market will reach a value of USD 5313 Million by 2032 at a CAGR of 6.8% MARKITWIRED